Literature DB >> 26613958

Novel mutation in an Egyptian patient with infantile Canavan disease.

Osama K Zaki1, Heba S El Abd2, Shaimaa A Mohamed3, Hatem Zayed4.   

Abstract

Canavan disease (CD) is a rare fatal childhood neurological autosomal recessive genetic disease caused by mutations in the ASPA gene, which lead to catalytic deficiency of the ASPA enzyme that catalyzes the deacetylation of NAA. It is a severe progressive leukodystrophy characterized by spongiform degeneration of the white matter of the brain. CD occurs frequently among Ashkenazi Jewish population, however it has been reported in many other ethnic groups with significantly lower frequency. Here, we report on a 2 year-old Egyptian child with severe CD who harbors a novel homozygous missense variant (c.91G > T, p.V31F) in the ASPA gene. The clinical, radiological, and molecular genetic profiles are reviewed in details.

Entities:  

Keywords:  Aspartoacylase; Canavan disease; MRI; MRS; N-acetyl-aspartate

Mesh:

Year:  2015        PMID: 26613958     DOI: 10.1007/s11011-015-9772-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  10 in total

1.  Case 99: Canavan disease.

Authors:  Steven J Michel; Curtis A Given
Journal:  Radiology       Date:  2006-10       Impact factor: 11.105

Review 2.  Canavan disease: an Arab scenario.

Authors:  Hatem Zayed
Journal:  Gene       Date:  2015-02-07       Impact factor: 3.688

Review 3.  Canavan disease: a white matter disorder.

Authors:  Shalini Kumar; Natalia S Mattan; Jean de Vellis
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

4.  Structure of aspartoacylase, the brain enzyme impaired in Canavan disease.

Authors:  Eduard Bitto; Craig A Bingman; Gary E Wesenberg; Jason G McCoy; George N Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

Review 5.  Magnetic resonance spectroscopy.

Authors:  Sachin K Gujar; Sharad Maheshwari; Isabella Björkman-Burtscher; Pia C Sundgren
Journal:  J Neuroophthalmol       Date:  2005-09       Impact factor: 3.042

6.  Identification of the zinc binding ligands and the catalytic residue in human aspartoacylase, an enzyme involved in Canavan disease.

Authors:  S Herga; J-G Berrin; J Perrier; A Puigserver; T Giardina
Journal:  FEBS Lett       Date:  2006-10-02       Impact factor: 4.124

7.  Consanguineous matings in the Egyptian population.

Authors:  M Hafez; H El-Tahan; M Awadalla; H El-Khayat; A Abdel-Gafar; M Ghoneim
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

8.  Mutational analysis of aspartoacylase: implications for Canavan disease.

Authors:  Jeremy R Hershfield; Nagarajan Pattabiraman; Chikkathur N Madhavarao; M A Aryan Namboodiri
Journal:  Brain Res       Date:  2007-03-03       Impact factor: 3.252

9.  Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.

Authors:  B J Zeng; Z H Wang; L A Ribeiro; P Leone; R De Gasperi; S J Kim; S Raghavan; E Ong; G M Pastores; E H Kolodny
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

Review 10.  Canavan disease: clinical features and recent advances in research.

Authors:  Hideki Hoshino; Masaya Kubota
Journal:  Pediatr Int       Date:  2014-08       Impact factor: 1.524

  10 in total
  4 in total

1.  Two patients with Canavan disease and structural modeling of a novel mutation.

Authors:  Osama K Zaki; Navaneethakrishnan Krishnamoorthy; Heba S El Abd; Soumaya A Harche; Reem A Mattar; Rana S Al Disi; Mariam Y Nofal; Rajaa El Bekay; Khalid A Ahmed; C George Priya Doss; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2016-08-17       Impact factor: 3.584

2.  Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases.

Authors:  D Thirumal Kumar; Hend Ghasan Eldous; Zainab Alaa Mahgoub; C George Priya Doss; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-06       Impact factor: 3.584

3.  Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I.

Authors:  Ahmed Mosaeilhy; Magdy M Mohamed; George Priya Doss C; Heba S A El Abd; Radwa Gamal; Osama K Zaki; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2017-04-07       Impact factor: 3.584

Review 4.  Clinical and Genetic Characteristics of Leukodystrophies in Africa.

Authors:  Mutaz Amin; Liena Elsayed; Ammar Eltahir Ahmed
Journal:  J Neurosci Rural Pract       Date:  2017-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.